Verona Pharma plc (I9SA) — Financial Flexibility Index
Verona Pharma plc (I9SA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of €30.56 Million (operating CF €30.56 Million minus capex €0.00) represents 0% of total liabilities (€294.60 Million). Check I9SA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verona Pharma plc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Verona Pharma plc across 9 annual periods. For the full cash flow conversion analysis, see Verona Pharma plc operating cash flow efficiency.
Annual Financial Flexibility Index for Verona Pharma plc (2016–2024)
Year-by-year free cash flow to debt coverage for Verona Pharma plc. Explore I9SA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | €-121.62 Million | €-122.20 Million | €269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | €-50.22 Million | €-50.22 Million | €58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | €-59.83 Million | €-59.86 Million | €29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | €-33.24 Million | €-33.25 Million | €38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | €-44.99 Million | €-45.08 Million | €19.35 Million | ▲ +19.8% |
| 2019 | -2.90x | €-42.81 Million | €-42.87 Million | €14.78 Million | ▼ -130.1% |
| 2018 | -1.26x | €-18.10 Million | €-18.11 Million | €14.37 Million | ▲ +20.8% |
| 2017 | -1.59x | €-20.69 Million | €-20.70 Million | €13.00 Million | ▼ -322.1% |
| 2016 | -0.38x | €-5.43 Million | €-5.59 Million | €14.40 Million | — |